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Abstract
The apolipoprotein E4 (ApoE4) is an established risk factor for Alzheimer’s disease (AD). Previous work has shown that this
allele is associated with functional (fMRI) changes as well structural grey matter (GM) changes in healthy young, middle-
aged and older subjects. Here, we assess the diffusion characteristics and the white matter (WM) tracts of healthy young
(20–38 years) ApoE4 carriers and non-carriers. No significant differences in diffusion indices were found between young
carriers (ApoE4+) and non-carriers (ApoE42). There were also no significant differences between the groups in terms of
normalised GM or WM volume. A feature selection algorithm (ReliefF) was used to select the most salient voxels from the
diffusion data for subsequent classification with support vector machines (SVMs). SVMs were capable of classifying ApoE4
carrier and non-carrier groups with an extremely high level of accuracy. The top 500 voxels selected by ReliefF were then
used as seeds for tractography which identified a WM network that included regions of the parietal lobe, the cingulum
bundle and the dorsolateral frontal lobe. There was a non-significant decrease in volume of this WM network in the ApoE4
carrier group. Our results indicate that there are subtle WM differences between healthy young ApoE4 carriers and non-
carriers and that the WM network identified may be particularly vulnerable to further degeneration in ApoE4 carriers as they
enter middle and old age.
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Introduction
Apolipoprotein E (ApoE) regulates the metabolism of lipids by
coordinating their transport and redistribution from one cell type
to another via ApoE receptors and proteins associated with lipid
transfer and lipolysis [1]. ApoE is thought to play a key role in
neuronal development and brain plasticity [2]. There are three
allelic variants of the ApoE gene in humans (E2, E3, E4) [3].
Although the frequency of the ApoE4 allele is low in humans,
primate studies suggest that it is the ancestral allele and it has been
hypothesized that the mutation leading to ApoE3 may have been
selected for during the evolution of the unique role of grand-
mothering in early humans which led to the spread of the E3 allele
[3].
The E4 allele has been shown to confer a higher risk of
developing both early onset and late onset AD [4,5]. Brain
structure and function have been found to be altered in ApoE4
carriers, both in AD patients [6–9] and in healthy subjects [10–
14]. Studies have found greater rates of temporal lobe atrophy in
AD patients with greater load of E4 allele [6,15–17] and reduced
medial temporal lobe volumes in healthy ApoE4 carriers across
the age spectrum [14,18–21]. However, a number of studies have
also failed to replicate these findings [22–24]. A mixed picture is
also found in terms of functional studies, with both increased
[6,9,25] and decreased [26,27] task-related BOLD signals
reported in carrier groups relative to non-carriers.
As the E4 allele has been related to several deleterious biological
effects, the question arises as to why it has persisted. Recent work
has suggested that the ApoE4 genotype might exert an
antagonistic pleiotropic effect [28] whereby carriers have con-
trasting effects across the lifespan, with significant negative effects
occurring in middle to old age, but with specific advantages noted
in healthy young carriers. This pleiotrophic effect of E4 may
account for some of the discrepancies noted in the studies above.
E4 has also been associated with higher IQ [29], a higher
education level [30], reduced cardiovascular response to experi-
mentally induced stress [31], a protective effect against spontane-
ous abortion during embryogenesis [32], and against perinatal
death [33]. Additionally, hippocampal LTP was enhanced at a
young age in knock-in mice expressing human APOE4 [34].
While the majority of studies to date have focussed on GM
changes, few studies have investigated the WM characteristics of
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the transport of lipids which in turn are used for the construction
of myelin sheaths [35,36], the role of WM development in ApoE4
carriers and non-carriers will clearly be of great importance. In
Alzheimer disease (AD) WM pathology has been shown to
correlate with disease severity [37–39]. WM changes may also be a
key indicator of early pathology [40] and WM damage in AD has
been highlighted both in postmortem studies [41] as well as in in
vivo MRI studies [42–44]. Degradation of WM microstructure can
occur secondary to grey matter (GM) pathology via an
accumulation of aggregated hyperphosphorylated tau protein
and the deposition of Ab [45]. There is also evidence for direct
WM damage occurring as a result of oligodendrocyte death and
reactive gliosis [46].
To date two previous DTI studies in healthy older people found
subtle but significant decreases in FA in the parahippocampal
gyrus [47] and in the splenium of the corpus callosum [48] in
ApoE4 carriers. A recent whole brain tract based spatial statistics
(TBSS) study found widespread significant differences between
healthy young carriers and non-carriers [49]. Therefore, the few
studies that exist indicate the possibility that ApoE4 carriers
exhibit WM damage in early adulthood.
The aim of the current study was to investigate the effect of
APOE genotype on WM structure in healthy young people.
Whole brain TBSS was applied to detect significant differences
that may be present between the groups. Diffusion data derived
from TBSS was also run through a feature selection algorithm
(ReliefF) [50] which identified the most salient voxels for group
classification that were subsequently employed in the training of a
support vector machine (SVM) classifier. The SVM was then used
to classify the two groups. The voxels selected by the ReliefF
algorithm were also used as seeds for probabilistic tractography.
We hypothesized that tractography initiated from seed voxels
selected by ReliefF would identify a WM network that may be
structurally different between carrier and non-carrier groups. We
also hypothesized that the SVM would be able to classify the two




The study was approved by the Ethics Committee of Goethe
University and was in accordance with the Declaration of
Helsinki. All participants provided informed written consent.
Participants
44 cognitively intact persons between 20 and 38 years of age, all
without any history of neurological or psychiatric disease were
assessed in the current study. These 44 subjects were drawn from a
larger cohort of 96 subjects. All of the 44 selected subjects were
right-handed, as assessed with the Edinburgh Handedness
Inventory [51] and provided written informed consent. Ethics
approval was obtained from the local ethics committee of JWG
University Frankfurt. All subjects underwent neuropsychological
assessment. Verbal learning and memory was assessed using the
German Version of the California Verbal Learning Test (CVLT)
[52,53], visual memory was tested with the Brief Visual Memory
Test - R (BVMT R) [54]. Additionally, measures of working
memory and attention were obtained using the Letter Number
Sequencing (LNS) [55], Spatial Span of the Wechsler Memory
Scale 3 (WMS SS) [56] and Trail Making Test A (TMT). The
verbal IQ was tested with a German verbal intelligence test
(Mehrfachwahl-Wortschatz-Test B; MWTB), in which subjects
had to indicate real words within lists of pseudo-words [57].
Depressive Symptoms were measured with the German Version of
the Beck Depression Inventory (BDI 2) [58,59].
All participants from the larger cohort (n=96) underwent
APOE genotyping using PCR and sequencing. For the current
analysis, 21 subjects who were heterozygote for ApoE4 (e3/e4)
and one subject who was homozygote for ApoE4 were included
into the e4+ group. 22 subjects, matched for age, gender and
education who were e4 negative (e3/e3) were included into the e4
group. Group characteristics are summarized in Table 1.
ApoE4 Genotyping
APOE genotyping of the two determinating variants rs7412 and
rs429358 was analyzed using pre-designed TaqMan SNP
Genotyping assays (Applied Biosystems, Foster City, CA). Briefly
for each SNP 20 ml reaction mix contained 15 ng genomic DNA,
unlabeled PCR primers, MGB labeled probes (VIC, 6FAM), 10 ml
of 26 TaqMan universal PCR Master Mix (Applied Biosystems,
Foster City, CA). PCR was performed on an ABI 7000 instrument
(Applied Biosystems, Foster City, CA) with the following cycling
programm: 95uC for 15 s, 40 cycles of 95uC for 15 s and 60uC for
60 s. The ABI 7000 genotyping software was used for allelic
discrimination.
Imaging Methods
All MR images were acquired using a Trio 3-T scanner
(Siemens, Erlangen, Germany) with a standard head coil for
radiofrequency transmission and signal reception. Participants
were outfitted with protective earplugs to reduce scanner noise and
a hand-held response device. For T1 weighted structural brain
imaging, an optimized 3D modified driven equilibrium Fourier
transform (3D MDEFT) sequence was used with the following




Variable Mean SD Mean SD T-value P-value
n=22 n=22
Age (years) 26.7 4.0 26.9 5.3 5.28 0.92
Gender (m/f) 13/9 13/9 0.76
Education (years) 16.8 4.5 17.0 4.3 20.15 0.88
MWTB 29.7 3.6 30.3 4.3 20.46 0.65
MWTB IQ 106.7 23.6 114.7 15.3 21.28 0.21
TMT (sec) 22.0 5.8 19.3 3.9 1.81 0.08
WMS SS 19.1 2.0 19.4 2.8 20.31 0.76
LNS 18.7 3.2 17.8 2.7 1.07 0.29
BVMT R 32.7 3.5 32.0 3.6 0.62 0.54
BDI 2 3.2 3.6 2.4 2.9 0.83 0.41
CVLT 66.8 8.0 64.5 9.1 0.90 0.37
Values are mean 6 standard deviation. Significance was set at p,0.05; thus no
significant differences were found between the groups. Values denote mean
and standard deviation or number of subjects. P-values refer to t-tests
(parametric tests) and chi-square tests (for categorial data). Abbreviations:
MWTB: Mehrfachwahl-Wortschatz-Test B, a German Verbal intelligence test;
TMT: trail making test; WMS SS: Spatial Span of the Wechsler Memory Scale;
LNS: Letter Number Sequencing; BVMT R: Brief Visual Memory Test R; BDI 2:
Beck Depression Inventory 2; CVLT: California Verbal Learning Test.
doi:10.1371/journal.pone.0036024.t001
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(TR)=7.92 ms, echo time (TE)=2.48 ms, field of
view=256 mm, 176 slices, 1.0 mm slice thickness.
DTI was acquired using an echo planar imaging (EPI) sequence
with the following pulse sequence: TR=8760 ms; TE=100 ms;
acquisition voxel size=26262m m
3; 60 axial adjacent slices; slice
thickness=2 mm (no gap); FOV=192 mm6192 mm6120 mm;
acquisition matrix=96696; 10 images without diffusion weighting
and 60 diffusion-encoding gradients applied in 60 noncollinear
directions; b-value=1000 s/mm
2; both the b0 and the 60
diffusion weighted images were averaged three times, band-
width=1302 Hz/pixel; total acquisition time=10 min 31 sec.
This sequence was acquired using generalised auto-calibrating
parallel acquisitions (GRAPPA; Griswold et al., 2002) with an
acceleration factor of 2.
For each subject a total of three consecutive DTI scans were
acquired. An average of these three scans was then created for use
in subsequent DTI processing.
A T2-weighted fluid attenuation inversion recovery (FLAIR)
sequence was also acquired to ensure that vascular pathology was
not significant. For all 44 subjects selected from the larger cohort,
no hyperintense white matter lesions were seen in the FLAIR
scans.
High Resolution T1W Structural Image Processing
Images were skull stripped with the Brain Extraction Tool
(BET) from the FSL library [60]. Brain tissue volume, normalized
for subject head size, was estimated with SIENAX [61,62], which
is part of the FSL library. SIENAX starts by extracting brain and
skull images from the single whole-head input data. The brain
image is then affine-registered to MNI152 space [63,64] (using the
skull image to determine the registration scaling); this is primarily
in order to obtain the volumetric scaling factor, to be used as a
normalization for head size. Next, tissue-type segmentation with
partial volume estimation is carried out [65] in order to calculate
total volume of brain tissue including separate estimates of
volumes of WM and GM.
DTI Processing
DTI analysis was performed using TBSS [66]. Images were
skull stripped with the Brain Extraction Tool (BET) from the FSL
library [60]. Raw DTI images were first corrected for motion and
eddy current effects. The diffusion tensor was then calculated with
the DTIFIT program for whole brain volumes and the resulting
FA maps, together with the DA (l1) and DR ((l2+l3)/2) and MD
((l1+l2+l3)/3) maps, were used in subsequent TBSS analysis.
TBSS performs a non-linear registration that aligns each FA
image to every other one and calculates the amount of warping
needed for the images to be aligned. The most representative
image is determined as the one needing the least warping for all
other images to align to it. The FSL library also provides a 1 mm
isotropic FA target image (FMRIB58_FA) in standard space,
which is sometimes used instead of the most representative image
from the study cohort. This can be problematic as the target image
is based on a young healthy brain. Using the method of ‘‘all
subject to all subject’’ registration is more computationally
intensively, but highly desirable when dealing with populations
other than young healthy controls. After this registration step,
warped versions of each subject’s FA image were generated which
were then averaged and a white matter ‘‘skeleton’’ was then
created suppressing all non-maximum FA values in each voxel’s
local-perpendicular direction and subsequently comparing all
remaining non-zero voxels with their nearest neighbours, thus
searching for the centre of fibre bundles. The skeleton was then
thresholded at an FA value of 0.2 which limits the effects of poor
alignment across subjects and ensures that GM and CSF voxels
are excluded from the skeleton. The resulting skeleton contained
WM tracts common to all subjects. A ‘‘distance map’’ is then
created which is used to project each FA image onto the mean FA
skeleton that is common to all subjects [66]. The same non-linear
transformations derived for the FA maps were applied to the DA,
DR and MD maps.
Following TBSS processing, a global region of interest was
created using the white matter skeleton that is common to all
subjects. Mean values of FA, DA, DR and MD were extracted
from each subject using this global ROI.
For statistical analysis, the images were analyzed using the
‘‘randomise’’ tool from FSL using a standard GLM design which
controlled for the effect of age and gender. Randomise computes
permutation tests on the assumption that the null hypothesis
implies complete exchangeability of the observations [67]. Using
this setup voxelwise differences between groups were then assessed,
setting the number of permutations at 5000 permutations.
Significance was tested at p,0.05 levels, corrected for multiple
comparisons using the ‘‘2D’’ parameter settings with threshold-
free cluster enhancement (TFCE), a method which avoids using an
arbitrary threshold for the initial cluster-formation [68].
Support Vector Machines Analysis
Classification of individual subjects was undertaken using the
freely available WEKA software package (http://www.cs.waikato.
ac.nz/ml/weka, Version 3.6.4) [69,70]. Following TBSS analysis,
the skeletonised FA, DA, DR and MD data was analysed in
Matlab (program written by FL and available on request), which
extracted the diffusion values from the WM skeleton. There were
132,208 voxels in the WM skeleton and diffusion values for all
indices of diffusion were extracted from each voxel in the WM
skeleton. Classification between carrier and non-carrier groups
was undertaken using each index of diffusion separately in order to
determine the most efficient index for classification.
The first step of the WEKA analysis was to reduce the number
of voxels to those that are most relevant for classification. This step
eliminates non-discriminative voxels which would reduce classifi-
cation accuracy. The feature selection algorithm ‘‘ReliefF’’ was
used to extract the most important voxels [50]. For each
classification group and also for each index of diffusion, eight
reduced datasets were created as follows:
1. 250 voxel dataset
2. 500 voxel dataset
3. 750 voxel dataset
4. 1000 voxel dataset
5. 2000 voxel dataset
6. 3000 voxel dataset
7. 4000 voxel dataset
8. 5000 voxel dataset
Therefore in total, 32 reduced datasets were created; i.e. 8
reduced datasets for each index of diffusion (FA, MD, DR and
DA). The choice of identifying these 8 datasets is based on
previous studies that have shown that this is an optimum range of
data reduction for successful classification [71–74].
The aim of the ReliefF algorithm is to estimate the quality of
voxels according to how well the value of a voxel distinguishes
between instances that are near to each other. The central idea of
ReliefF is to estimate the quality of voxels according to how well
their values distinguish between instances that are near to each
Tractography in ApoE+ and ApoE- Subjects
PLoS ONE | www.plosone.org 3 April 2012 | Volume 7 | Issue 4 | e36024other [50,75]. Given a randomly selected instance Insm from class
L, ReliefF searches for K of its nearest neighbours from the same
class called nearest hits H, and also K of its nearest neighours from
each of the different classes, called nearest misses M. It then
updates the quality estimate Wi for voxel i based on the values for
Insm, H and M. If instance Insm and those in H have different values
for voxel i, then the quality estimation Wi is decreased.
Alternatively, if instance Insm and those in M have different values
on the voxel i, then Wi is increased [50,75].
After reducing the data into the three datasets of differing sizes,
classification was then performed using the SVM algorithm
‘‘sequential minimal optimization’’ (SMO) [76] with a radial basis
function (RBF) kernel [77]. SVMs are algorithms that learn how to
assign labels to objects [78]. They use linear models to implement
nonlinear class boundaries by transforming the input into a new
higher dimensional space. In this way, a straight line in the new
space can be curved or non-linear when transformed back to the
original lower-dimensional space. Following transformation, a
linear model called the maximum margin hyperplane is created.
To visualise this, imagine a dataset with two-classes that are
linearly separable. The maximum margin hyperplane is the one
that gives the greatest separation between the classes. The
hyperplane describes a straight line in a high-dimensional space,
and therefore a separating hyperplane is a line that separates the
classes. The instances that are closest to the maximum margin
hyperplane are called support vectors. A unique set of support
vectors defines the maximum margin hyperplane for the learning
problem. Once the support vectors for the two classes are
established, a maximum margin hyperplane can be constructed.
The projection of the data from low dimensional space to higher
dimensional space is achieved with a kernel function. The optimal
kernel function is usually found by trial and error [78]. In the
current study a radial basis function (RBF) kernel was used to
nonlinearly map samples into a higher dimensional space. RBF
kernels use two parameters: C and GAMMA. GAMMA represents
the width of the radial basis function, and C represents the error/
trade-off parameter that adjusts the importance of the separation
error in the creation of the separation surface [79]. C was fixed to
1 and GAMMA was fixed to 0.01. During each trial, tenfold cross
validation was used for classification. This involves dividing the
data into 10 parts. Nine parts were used for training and one part
for testing. This was repeated 10 times, resulting in the learning
algorithm being implemented 100 times on datasets that are all
nine-tenths the size of the original [69,70]. This is a standard
procedure in machine learning which reduces the variation related
to data selection and allows results to be averaged to yield robust
calculations of the performance of the SVM. During each of the
ten repetitions within a given trial, the same values of C and
GAMMA are retained for each repetition.
For the analysis of results, measures of sensitivity, specificity and
an F-measure were used. An F-measure is used to give a single
measure that can characterise overall performance [70]. An F-
measure is the harmonic mean of Precision and Recall.
A workflow, outlining the creation of the WM skeleton, the
extraction of diffusion values from each point on the WM skeleton,
the reduction of the data using ReliefF and the application of the
SVM is shown Fig. 1.
Tractography
Seeds were created from the significant clusters created from the
ReliefF algorithm, and these seeds were used for probabilistic
tractography [80]. In order to perform the probabilistic tracto-
graphy in standard space for each subject, we fed both warpfields
generated with FNIRT when registering individual subjects to
standard space, and their corresponding inversed warpfields into
the tractographic algorithm. A multi-fibre model was fit to
diffusion data at each voxel which allows tracing of fibres through
regions of fibre crossing and complexity [81]. At each voxel, a
probability distribution function (pdf) is estimated on each fibre
direction. Tractography then proceeds by drawing multiple (in this
case 5,000) streamline samples through these pdfs from each seed
voxel to create an estimate of the distribution of connections from
each seed voxel. When these streamlines reach a voxel in which
more than one direction is estimated they follow the direction that
is closest to parallel with the direction at which the streamline
arrives. Generated pathways are volumes in which values at each
voxel represent the number of samples passing through that voxel
and, therefore, the probability of connection to the seed voxel. To
remove spurious connections, pathways in individual subjects were
thresholded to include only voxels which had at least 250 samples
passing through them (out of 5,000) generated from each seed
voxel. These pathways were then binarised and overlaid to create
population probability maps in which voxel values represent the
number of subjects in whom a pathway is present. As is noted in
the Results and Discussion sections, tractography was performed
using the seed points from the FA dataset because this diffusion
index produced the greatest classification accuracy.
Results
Demographic and Cognitive Characteristics
There were no significant differences between the groups in
terms of any of the demographic or psychological measures taken
(Table 1).
Normalised Grey Matter and White Matter Volumes
Normalised Grey Matter and White Matter Volumes were not
significantly different between groups (p.0.05) (Fig. 2).
Differences in Multiple Indices of Diffusion between
ApoE4 Carriers and Non-Carriers
After correcting for multiple comparisons no significant
voxelwise differences were found between the two groups using
randomise permutation testing of the TBSS images. Global
boxplots for the four indices of diffusion can be seen in Figure 3.
The diffusion values in these boxplots are taken from the entire
white matter skeleton.
SVM Classification of ApoE4 Carrier and Non-Carrier
The ReliefF algorithm was used to reduce the FA, DA, DR and
MD datasets to datasets that contain the most salient voxels for
group classification. Figure 4(a) presents a graphical depiction of
the reduction of the FA dataset by ReliefF to the 500 most import
voxels as judged by the weighting procedure described in the
methods. The volume of clusters is noted on the y-axis. Figure 4(b)
depicts the anatomical location of some of the voxels selected by
ReliefF following the reduction of the FA dataset. The largest
cluster of voxels is also indicated in the figure. The same process
was followed when reducing the FA data to 250, 750, 1000, 2000,
3000, 4000 and 5000 voxel datasets. The entire procedure was
repeated for the DR, MD and DA datasets.
The reduced datasets were then used by the SVM for training
and subsequent classification of ApoE4 carriers and non-carriers.
An SVM analysis was performed separately using FA, DA, DR
and MD datasets. The results from these four different SVM
analyses are shown in Figure 5. The FA data produced the best
overall performance, with sensitivity and specificity ranging from
93 to 100%. For the DA, DR and MD indices of diffusion,
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specificity in the range of 86–100% (Fig. 5).
Tractography
As the voxels selected by ReliefF from the FA dataset produced
the best overall performance in terms of group classification, the
top 500 voxels from the FA data were used as seed points for
tractography. Thus, tracts were initiated from all 500 of these
voxels using probabilistic tractography in each ApoE4 carrier and
non-carrier subject.These tracts (binarised at a threshold of 250
out of 5000 streamlines) are overlaid to create population
probability heatmaps in which each voxel value represents the
number of subjects in whom a pathway is present (Fig. 6). These
population probability heatmaps highlight the WM network that is
initiated from the 500 voxel seed created with the ReliefF
Figure 1. Workflow for the processing of white matter diffusion information. (1) Following TBSS processing a white matter skeleton is
created which is common to all subjects. Diffusion values are then extracted from every voxel in the white matter skeleton using a custom made
matlab script. Data is then labelled as either ApoE4 carrier or non-carrier. (2) Following preparation of the data into a WEKA compatible format the
data is reduced using a feature selection algorithm, ReliefF. This algorithm selects the most salient voxels for group classification. These voxels are
then used for training a support vector machine (SVM) classifier and subsequently the classification is performed with this classifier. The lowermost
figure shows a readout of top 500 voxels selected from the full FA dataset. The y-axis represents the volume of particular clusters and the location of
the largest cluster is shown circled in white in the anatomical images.
doi:10.1371/journal.pone.0036024.g001
Figure 2. Normalised WM (left) and GM (right) volumes for
healthy young ApoE4 carrier and non-carrier groups. No
significant differences were found between the groups for either WM
or GM volumes.
doi:10.1371/journal.pone.0036024.g002
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chosen by ReliefF as being the most useful for locating differences
between the groups, these heatmaps give an indication of tracts
that may be susceptible to micro and macrostructural damage in
ApoE4 carriers. The WM network implicated in both carrier and
non-carrier groups extends into much of the parietal lobe,
including the posterior cingulum and precuneus. The forceps
major, forceps minor, superior longitudinal fasciculus, as well as
the uncinate fasciculus and large portions of the prefrontal cortex
are also implicated. Finally, an analysis of the total volume of tracts
created from this 500 voxel seed is shown in Figure 7. ApoE4
carriers exhibited a non-significant (p=0.45, t=0.76) decrease in
tract volume relative to non-carriers (Fig. 7). Mean tract volume
was 190311.3 (SD 13151.6) mm
3 for ApoE4 carriers and 193441.9
(SD 14105.5) mm
3 for ApoE4 non-carriers.
Discussion
The current results show that it is possible to classify healthy
young ApoE4 carriers and non-carriers using an automated
Figure 3. Boxplots showing the distribution of diffusion tensor MRI indices for the global WM skeleton in ApoE4 carriers (red) and
non-carriers (white). The boxplots represent the interquartile ranges, which contain 50% of individual subjects’ values. The whiskers are lines that
extend from the box to the highest and lowest values. No significant differences were found between the groups.
doi:10.1371/journal.pone.0036024.g003
Figure 4. Voxels selected by the ReliefF algorithm as the most salient for group classification. (a) A graph of the most significant clusters
of voxels selected by the ReliefF algorithm. This graph shows the cluster label on the x-axis and the volume of the contiguous clusters on the y-axis.
(b) A selection of the top 500 voxels identified by the ReliefF algorithm. The white circles highlight the location of the largest cluster as identifiedb y
the previous graph. Note that this figure highlights the reduction of the entire FA dataset to the top 500 voxels. This process is followed for the top
250, 500, 750, 1000, 2000, 3000, 4000 and 5000 voxels of the FA dataset. This entire procedure is also repeated for DA, MD and DR datasets. The
coordinates shown for each slice are MNI coordinates in millimetres. The labels L and R indicate left and right respectively. The middle panel (x=40)
indicates a sagittal slice in the right hemisphere.
doi:10.1371/journal.pone.0036024.g004
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groups. Previous work has distinguished between healthy older
subjects and subjects with mild cognitive impairment (MCI) using
a combination of DTI and SVMs [74] but to the best of our
knowledge no machine learning paradigm has attempted to
classify healthy young ApoE4 carriers and non-carriers. Using
diffusion data in combination with an SVM, our machine learning
approach was able to classify ApoE4 carrier and non-carrier
groups with an extremely high degree of accuracy.
Of note is the fact that the FA index produced the best
classification performance. This is in line with a previous SVM
classification study which also found that FA gave the greatest
accuracy for the classification of healthy control and MCI subjects
[74]. The reduced FA dataset was studied in further detail to assess
the locations of the voxels selected by the ReliefF algorithm. This
feature selection algorithm is able to effectively provide quality
estimates for each voxel in the white matter skeleton. It has
previously been used successfully in a number of different domains
including genetics [82] and proteomics [83], and has recently
begun to be used in MRI [74]. In the current study we see that it
filters out irrelevant voxels and selects the most useful voxels which
can be used by an SVM for training and classification. The largest
cluster identified by ReliefF from the FA dataset was found in the
right anterior parietal region. Interestingly, this region has been
shown to demonstrate increased BOLD response in older ApoE4
carriers relative to non-carriers during picture learning [13].
It has been suggested, on the basis of functional changes in
ApoE4 carriers, that the E4 allele modulates neuronal activity
decades before any expression of disease [8,84]. A significant
interaction between age and E4 status has also been noted in the
frontal lobe and other areas, such that aging was associated with
decreased activity in E4 carriers and increased activity in non-
carriers [85]. Therefore the ApoE genotype determines age-
related changes in brain function that may reflect the increased
vulnerability to cognitive decline in later life. Our finding of a
subtle reduction in tract volumes in carriers may also be an
indicator of an increased vulnerability of ApoE4 carriers in the
tracts identified by tractography.
Also of note is the fact that 63% of the voxels (315 out of 500
voxels) selected by ReliefF were located in the right hemisphere.
Laterality effects have been noted in a number of ApoE4 studies
and evidence suggests that frontal-executive processes may be
responsible for mediating a right hemisphere compensation in
older age [86] [10] [87]. Bondi and colleagues found that the
anterior cingulate was directly implicated in a right hemisphere
compensatory mechanism response in healthy older ApoeE4
carriers [87]. Laterality effects have also been noted in older
ApoE4 carriers during an object naming task, where carriers were
found to have greater right perisylvian activation [88]. Overall,
Figure 5. Sensitivity, Specificity and F-measure for SVM run on ApoE4+ and ApoE42 subjects. The F-measure is the harmonic mean of
precision and sensitivity and can be used as a single measure of performance of the classification.
doi:10.1371/journal.pone.0036024.g005
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heightened degree in older ApoE4 carriers in order to compensate
for early declines in episodic memory. Although the underlying
reasons for this laterality are not known it is of interest that a
model of aging, termed HAROLD (hemisphere asymmetry
reductions in older adults) [89] posits that there is an age-related
loss of hemispheric asymmetry of task-related activation in the
prefrontal cortex (PFC). While healthy young subjects show
greater activation in left PFC compared with the right PFC during
the execution of a variety of cognitive tasks, many studies indicate
that this laterality is reduced in older subjects [89–93]. This loss of
laterality is frequently related to increased right PFC activation in
older adults which has been suggested to serve as a possible
compensatory mechanism in order to maintain cognitive perfor-
mance in older age. The large number of functional activation
studies showing increased right hemisphere functional activation
in older age [89–93] may serve as indirect evidence for chronically
stressed right hemisphere structures being predilection sites for
structural alterations in neurodegenerative diseases such as AD.
Subjects at genetic risk of AD (e.g. ApoE4 carriers) may display an
increased vulnerability of these same predeliction sites to structural
damage even at younger ages. A number of recent MCI and AD
dementia classification studies have also noted a right-more-than-
left pattern WM damage [94–96]. It is tempting to consider that
ReliefF’s identification of a large number of clusters in the right
hemisphere, may represent key WM nodes in ApoE4 carriers
which may be particularly sensitive to WM damage in later life
when the negative effects of the ApoE4 gene become more
pronounced.
The WM tracts initiated from the 500 voxels selected by ReliefF
include significant portions of the parietal lobe, the cingulum, the
dorsolateral prefrontal cortex, forceps major, forceps minor and
the uncinate fasciculus. It is of interest that the posterior parietal
lobe including the posterior cingulum/precuneus is part of the
network identified, as this is also an important hub which sustains
information transfer between the parahippocampal gyrus and the
prefrontal cortex [94,97]. A number of studies have proposed that
damage to the posterior cingulum/precuneus leads to dysfunction
of a network that is responsible for sustaining memory function
[42,94,97–99]. The precuneus is connected to the temporal lobe
via the retrosplenial cortex, and the hippocampus may not be able
to communicate with the neocortex if it is sufficiently damaged
[94,97,98]. PET studies have also highlighted reduced metabolism
in the posterior cingulum and the prefrontal cortex in both MCI
and AD subjects [100,101].
Analysis of the total volume of tracts initiated from the 500
voxel seed indicates a non-significant decrease in volume in the
ApoE4 carrier group. Overall, these results suggest that there are
subtle structural WM differences between ApoE4 carriers and
non-carriers. When considered together with evidence from
previous studies, it is possible that while the structural differences
are subtle at a young age, the WM network that has been
highlighted by tractography may be more susceptible to further
structural damage in ApoE4 carriers as they progress into middle
and old age.
It is of particular interest that although no significant differences
were found between the groups for any index of diffusion when
inspecting TBSS results that are corrected for multiple compar-
isons, the voxels selected by ReliefF could still be employed by an
SVM for successful classification. The reason for this lies in
methodological differences between the two approaches. For
TBSS, each voxel is assigned a t-value that is corrected for
Figure 6. Tractography using seed points selected by the
ReliefF algorithm for ApoE4 carriers and non-carriers, after
reducing the full FA dataframe. Here we have heatmaps created
from tracts that were thresholded at 250 out of 5,000 streamlines. At
one end of the scale, the bright green (ApoE4 non-carrier) or bright red
(ApoE4 carrier) indicates that tracts were present in all 22 subjects in
each group, whereas at the other end, the dark green or dark blue
indicates that tracts were present in 10 out of the total number of 22
subjects in each group.
doi:10.1371/journal.pone.0036024.g006
Figure 7. Volume of tracts produced using a seed of the top
500 voxels created by the ReliefF algorithm from the full FA
dataset. The tracts were thresholded to include only WM tracts that
contained 250 or more streamlines, out of a total of 5000 streamlines.
ApoE4 carriers exhibited a non-significant (p=0.45, t=0.76) decrease in
tract volume relative to non-carriers (Fig. 7). Mean tract volume was
190311.3 (SD 13151.6) mm
3 for ApoE4 carriers and 193441.9 (SD
14105.5) mm
3 for ApoE4 non-carriers.
doi:10.1371/journal.pone.0036024.g007
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total of 132,208 voxels in the entire white matter skeleton. The
level of correction for multiple comparisons is therefore extremely
high due to the large number of total voxels to be considered.
However, the SVM approach is underpinned by a different
theoretical framework. First, the most salient voxels are identified
using the ReliefF algorithm. After this data reduction step the
majority of voxels in the WM skeleton are discarded as irrelevant
for subsequent SVM classification. Therefore, the SVM only
considers the voxels identified by ReliefF in its calculation of a
single parameter per subject, and does not run into the problem of
multiple comparison biases [74].
It should be stressed that possession of the ApoE4 allele does not
automatically imply the possibility of cognitive or structural deficits
within the carrier group. A growing body of evidence suggests that
the ApoE4 genotype may confer some beneficial effects at a young
age, while being detrimental in older age [29–34]. Thus, there
may be evolutionary reasons for the retention of the ApoE4
genotype because of its possible beneficial effects at a young age,
which is offset by an increased risk of cognitive deficits in older
age. Results from the current study however suggest that the
ApoE4 gene may have no beneficial effects on WM structure in
healthy young people.
On the basis of the current results, subtle microstructural WM
differences do appear to be present in healthy young carrier
subjects, which can be utilised by SVMs for group classification.
The approach outlined in this study may offer a way to study a
particular WM network longitudinally, based on the hypothesis
that the network identified will be preferentially susceptible to
structural damage in ApoE4 carriers in later life.
Only one previous study has examined structural WM
differences between healthy young carrier and non-carrier groups
[49]. The current results which found no significant corrected
TBSS differences between the groups are at odds with this
previous study which found significant FA decreases in young
carriers relative to non-carriers. In fact, the FA reductions in
young carriers relative to non-carriers found by Heise and
colleagues appeared to be as widespread as the FA reductions
noted previously in Alzheimer’s patients relative to healthy older
controls [42,43,98]. The age, sample size and overall demo-
graphics of the current cohort are comparable to those of Heise
and colleagues; therefore, it might be possible that larger sample
sizes need to be employed in future studies in order to determine
whether or not widespread FA reductions in healthy young
ApoE4 carriers relative to non-carriers can be replicated in the
future.
To the best of our knowledge this is the first attempt to classify
healthy young ApoE4 carrier and non-carrier groups with
machine learning techniques. The use of 10 times 10-fold cross-
validation [70] ensures the robustness and generality of the results
by running the learning algorithm 100 times during each
experiment. This method also reduces the effect of random
variation when different folds are selected [69]. The use of a joint
TBSS/SVM analysis allows information to be used from the entire
brain which is a significant advantage over ROI based approaches
for classification. The current methodology also obviates the need
for the labour intensive selection and creation of ROIs.
Some limitations of the study should be noted. While the TBSS
approach strives to avoid the problems of voxel based morphology
relating to partial voluming, small WM tracts may still be
contaminated with GM if the tract width is smaller than the
original voxel size [66]. However, applying an FA threshold of 0.2
or less to the WM skeleton in the TBSS preprocessing steps is
thought to remove the potential occurrence of GM. It should also
be noted that probabilistic tractography is influenced not only by
the true underlying probability of an anatomical connection, but
also by factors such as the distance from a seed voxel and the
geometry of the pathways being tracked with more tortuous
pathways or pathways involving crossing fibers being more difficult
to track [81]. Probabilistic tractography is also insensitive to the
polarity of axonal projections. However, the probabilistic method
employed in the current study uses multi-fibre tractography which
offers significant advantages over deterministic methods when
tracking difficult white matter tracts such as those that include
crossing fibres [81]. It is important to note that due to the
difficulties of obtaining sufficient numbers of ApoE4 carriers, it has
not been possible to validate the current SVM method in an
independent sample. While 10 times 10-fold cross validation was
used to ensure performance generalisation, validation in an
independent sample will be essential to determine how robust
the current approach is when applied to a fully independent
dataset. Recent work adopting the current pipeline has been
successfully used to classify DTI images from older subjects into
MCI and healthy older categories [72]. While these findings from
an older cohort support the validity of the SVM approach outlined
here, caution should nevertheless be exercised before the method
is validated in an independent sample. This is currently being
pursued as part of the European DTI Study in Dementia (EDSD)
initiative.
Overall, the current study demonstrates the efficacy of using
DTI in conjunction with SVMs to classify ApoE4 carrier and non-
carrier groups. The feature selection algorithm, ReliefF, allowed
us to develop tractography from key seed regions that were
identified as having significantly different diffusion properties
between carrier and non-carrier groups. The current results
suggest that there are very subtle structural differences between
healthy ApoE4 carrier and non-carrier subjects, with carriers of
the ApoE4 allele showing slight reductions in the volume of white
matter tracts initiated from the seed regions identified by ReliefF.
The white matter network developed from these seed regions,
which incorporates the posterior and anterior cingulum, the
precuneous, and the prefrontal cortex, may represent a WM
network that is more susceptible to structural damage over the life
course of ApoE4 carriers. Longitudinal studies would be needed to
assess the diffusion properties and development of these tracts over
the life span of ApoE4 carriers and non-carriers.
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